ALENURA
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90502530
- Registration number
- 7680576
- Mark type
- Stylized text
- Filed
- 01 Feb 2021
- Published for opposition
- 05 Oct 2021
- Registered
- 04 Feb 2025
- Attorney of record
- Joseph Agostino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of urological ailments; Pharmaceutical preparations for the treatment of interstitial cystitis and bladder pain syndrome (IC/BPS)
Owner
- Urigen Pharmaceuticals Inc., Bound Brook, NJ, US
- Urigen Pharmaceuticals Inc., Bound Brook, NJ, US
- Urigen Pharmaceuticals Inc., Bound Brook, NJ, US
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Jan 2025 — HIDDEN SENSITIVE CONTENT
- 16 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Nov 2024 — USE AMENDMENT FILED
- 26 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 30 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2024 — SOU EXTENSION 5 GRANTED
- 29 May 2024 — SOU EXTENSION 5 FILED
- 29 May 2024 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2023 — SOU EXTENSION 4 GRANTED
- 30 Nov 2023 — SOU EXTENSION 4 FILED